Soohee Cho

Soohee Cho, MD, MSCS

Languages spoken: English

Clinical Locations

Huntsman Cancer Hospital

801-587-4745

Primary Children's Hospital

Cancer Blood and Marrow Clinic
801-662-4700

Primary Children's Hospital - Lehi

  • Dr. Cho is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Bone Marrow Transplant and Immunology Team at the University of Utah and Primary Children’s Hospital. He received his medical degree from Emory University, where he also completed his residency.

    Dr. Cho pursued his Pediatric Hematology and Oncology Fellowship at the University of Colorado School of Medicine, where he also received his degree in Clinical Science. He went on to complete his advanced fellowship in Pediatric Bone Marrow Transplant at the University of California, San Francisco School of Medicine.

    Dr. Cho is board-certified in Pediatrics and Pediatric Hematology and Oncology. Dr. Cho’s clinical interests include the treatment of pediatric disorders requiring bone marrow transplant. He has an emphasis on high-risk hematologic malignancies and cellular therapy designed to reduce toxicity in patients with relapsed and refractory disease.

    His primary research focuses on supportive care in children receiving bone marrow transplants and cellular/immunotherapy products.

    Specialties

    Board Certification

    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

  • Dr. Cho is currently an assistant professor at the University of Utah School of Medicine in the division of Pediatric Hematology/Oncology. He is a member of the Bone Marrow Transplant and Immunology Team at the University of Utah and Primary Children’s Hospital. He received his medical degree from Emory University, where he also completed his residency.

    Dr. Cho pursued his Pediatric Hematology and Oncology Fellowship at the University of Colorado School of Medicine, where he also received his degree in Clinical Science. He went on to complete his advanced fellowship in Pediatric Bone Marrow Transplant at the University of California, San Francisco School of Medicine.

    Dr. Cho is board-certified in Pediatrics and Pediatric Hematology and Oncology. Dr. Cho’s clinical interests include the treatment of pediatric disorders requiring bone marrow transplant. He has an emphasis on high-risk hematologic malignancies and cellular therapy designed to reduce toxicity in patients with relapsed and refractory disease.

    His primary research focuses on supportive care in children receiving bone marrow transplants and cellular/immunotherapy products.

    Board Certification and Academic Information

    Academic Departments Pediatrics -Primary
    Board Certification
    American Board of Pediatrics (Pediatrics)
    American Board of Pediatrics (Sub: Pediatric Hematology-Oncology)

    Education history

    Fellowship Pediatric Bone Marrow Transplant - University of California, San Francisco School of Medicine Fellow
    Clinical Science - University of Colorado School of Medicine MSCS
    Fellowship Pediatric Hematology/Oncology - University of Colorado School of Medicine Fellow
    General Pediatrics - Emory University School of Medicine Resident
    Professional Medical Medicine - Emory University School of Medicine M.D.
    Biochemistry - Georgia Institute of Technology B.S.

    Selected Publications

    Journal Article

    1. Cho S, Vigers T, Pyle L, Franklin A, Sopfe J, Jeney F, Forlenza G (2022). Composite Metric of Glycemic Control Q-Score Is Elevated in Pediatric and Adolescent/Young Adult Hematopoietic Stem Cell Transplant Recipients. Diabetes Technol Ther, 25(2), 116-121.
    2. Eckard AR, Cho S, ORiordan MA, McComsey GA (2016). Kallistatin levels in HIV-infected patients and effects of statin therapy. Biomarkers, 22(1), 55-62.
    3. Vegh RB, Solntsev KM, Kuimova MK, Cho S, Liang Y, Loo BL, Tolbert LM, Bommarius AS (2011). Reactive oxygen species in photochemistry of the red fluorescent protein "Killer Red". Chem Commun (Camb), 47(17), 4887-9.

  • News & Podcasts